Nouscom
  • Home
  • About
  • Technology
  • Pipeline
  • Investors
  • News
    • Grants
    • External presentations
    • Press Releases
    • Scientific publications
    • Conferences
  • Contact
Next-generation treatment for cancer Next-generation treatment for cancer Next-generation treatment for cancer Next-generation treatment for cancer
  • Home
  • About
  • Technology
  • Pipeline
  • Investors
  • News
    • Grants
    • External presentations
    • Press Releases
    • Scientific publications
    • Conferences
  • Contact

Archives

Monthly Archive for: "Ottobre, 2021"
Home » Archivi per Ottobre 2021
0

Dr. Elisa Scarselli will join as Expert Speaker at the virtual Neoantigen Based Therapies Summit

Our Co-Founder and CSO Dr. Elisa Scarselli will join as Expert Speaker at the virtual Neoantigen Based Therapies Summit from October 26 – 28, 2021. Find out more about the conference and [...]

READ MORE
0

Dr. Marina Udier looks forward to presenting @Chardan for their 5th Annual Genetic Medicines Conference on October 4th at 3 pm CET.

Dr. Marina Udier looks forward to presenting @Chardan for their 5th Annual Genetic Medicines Conference on October 4th at 3 pm CET. Nouscom is one of 90+ public and private genetic medicines [...]

READ MORE
Contact
  • NOUSCOM
  • info@nouscom.com
  • nouscom.com
Our Privacy

Privacy Policy & Cookie Low

Nouscom is a private oncology company developing next generation immunotherapies, founded in 2015 by an experienced management team that has worked together for many years in previous successful enterprises. Nouscom’s proprietary technology platform harnesses the full power of the immune response by combining viral vectored genetic vaccines based on neoantigens with other immunomodulators.

© Copyright 2018 | Made with by
error: Content is protected !!!